Search Results (64)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Bonetto, Andrea | Person |
Why?
|
| ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia. | Academic Article |
Why?
|
| STAT3 in the systemic inflammation of cancer cachexia. | Academic Article |
Why?
|
| ?-hydroxy-?-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. | Academic Article |
Why?
|
| The urgent need to improve childhood cancer cachexia. | Academic Article |
Why?
|
| FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness. | Academic Article |
Why?
|
| IGF-1 is downregulated in experimental cancer cachexia. | Academic Article |
Why?
|
| PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia. | Academic Article |
Why?
|
| Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia. | Academic Article |
Why?
|
| Role of myokines and osteokines in cancer cachexia. | Academic Article |
Why?
|
| STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. | Academic Article |
Why?
|
| The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia. | Academic Article |
Why?
|
| Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. | Academic Article |
Why?
|
| Postoperative consequences of cancer cachexia after head and neck free flap reconstruction. | Academic Article |
Why?
|
| Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia. | Academic Article |
Why?
|